|
|||||
|
|
Bone Health and Denosumab Discontinuation in Oncology Populations |
|
| Authors: | Yee-Ming Melody Cheung Alicia Morgans Ole-Petter Riksfjord Hamnvik |
| Affiliation: | Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA, USA;Department of Medicine, Endocrine Unit, Austin Hospital, The University of Melbourne, Victoria, Australia;Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA |
| Abstract: | |
| Keywords: | bone health cancer denosumab discontinuation multiple vertebral fractures rebound phenomenon |